Znanstveni rad - Izvorni znanstveni rad
Targeting Natural Killer Cell Reactivity by Employing Antibody to NKp46: Implications for Type 1 Diabetes
PLOS ONE, 10 (2015), 2; e0118936. https://doi.org/10.1371/journal.pone.0118936

Yossef, Rami; Gur, Chamutal; Shemesh, Avishai; Guttman, Ofer; Hadad, Uzi; Nedvetzki, Shlomo; Miletić, Antonija; Nalbandyan, Karen; Cerwenka, Adelheid; Jonjić, Stipan; Mandelboim, Ofer; Porgador, Angel

Citirajte ovaj rad

Yossef, R., Gur, C., Shemesh, A., Guttman, O., Hadad, U., Nedvetzki, S. ... Porgador, A. (2015). Targeting Natural Killer Cell Reactivity by Employing Antibody to NKp46: Implications for Type 1 Diabetes. PLOS ONE, 10. (2). doi: 10.1371/journal.pone.0118936

Yossef, Rami, et al. "Targeting Natural Killer Cell Reactivity by Employing Antibody to NKp46: Implications for Type 1 Diabetes." PLOS ONE, vol. 10, br. 2, 2015. https://doi.org/10.1371/journal.pone.0118936

Yossef, Rami, Chamutal Gur, Avishai Shemesh, Ofer Guttman, Uzi Hadad, Shlomo Nedvetzki, Antonija Miletić, et al. "Targeting Natural Killer Cell Reactivity by Employing Antibody to NKp46: Implications for Type 1 Diabetes." PLOS ONE 10, br. 2 (2015). https://doi.org/10.1371/journal.pone.0118936

Yossef, R., et al. (2015) 'Targeting Natural Killer Cell Reactivity by Employing Antibody to NKp46: Implications for Type 1 Diabetes', PLOS ONE, 10(2). doi: 10.1371/journal.pone.0118936

Yossef R, Gur C, Shemesh A, Guttman O, Hadad U, Nedvetzki S, i sur.. Targeting Natural Killer Cell Reactivity by Employing Antibody to NKp46: Implications for Type 1 Diabetes. PLOS ONE [Internet]. 26.02.2015. [pristupljeno 01.12.2021.];10(2). doi: 10.1371/journal.pone.0118936

R. Yossef, et al., "Targeting Natural Killer Cell Reactivity by Employing Antibody to NKp46: Implications for Type 1 Diabetes", PLOS ONE, vol. 10, br. 2, Veljača 2015. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:468753. [Citirano: 01.12.2021.]

Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.